Evaluation of IL-1β and IL-6 Expression following EBNA-1 and BRLF-1 Peptide Treatment in Epstein-Barr Virus-Positive Multiple Sclerosis Patients

INTRODUCTION: Epstein-Barr virus (EBV/HHV-4) has been implicated in the pathogenesis of multiple sclerosis (MS). This study was conducted to investigate the levels of pro-inflammatory cytokines IL-1β and IL-6 in healthy EBV carriers and MS patients with prior EBV infection in response to treatment w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kianfar, Roya, Ravanshad, Mehrdad, Ghiass, Mohammad Adel, Rafiee, Nastaran, Shayeghpour, Ali, Maleki, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501781/
https://www.ncbi.nlm.nih.gov/pubmed/35158367
http://dx.doi.org/10.1159/000522577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501781/
https://www.ncbi.nlm.nih.gov/pubmed/35158367
http://dx.doi.org/10.1159/000522577

Ejemplares similares